Table 1 Socio-demographic description of the reduction and validation samples
Reduction Sample N = 152 | Validation Sample N = 148 | |
|---|---|---|
Age (years): Mean (SD) | 49.5 (7.8) | 47.9 (8.4) |
Studies (%) | ||
Primary | 39.1 | 28.9 |
Secondary | 31.1 | 33.8 |
Graduate | 29.8 | 37.3 |
Actual couple: Yes (%) | 98.7 | 97.9 |
Relationship (years): Mean (SD) | 23.7 (11.5) | 24.1 (10.2) |
Contraceptive: Yes (%) | 31.3 | 46.9 |
Climacteric stage (%) | ||
Pre-menopause | 12.6 | 25.3 |
Perimenopause | 14.6 | 14.4 |
Post-menopause | 72.8 | 60.3 |
Breast-Conserving Surgery (%) | 58.3 | |
Mastectomy (%) | 42.9 | |
Severity (%) | ||
Stage I | 47.3 | |
Stage II | 42.5 | |
Stage III | 9.5 | |
Adjuvant Chemotherapy (%) | 85.5 | |
Duration (month): Mean (SD) | 5 (2.87) | |
Adjuvant Hormonotherapy (%) | 82.6 | |
Duration (month); Mean (SD) | 50.4 (NR) | |
Complementary Radiotherapy (%) | 81.5 | |